News » Visby Medical Appoints Industry Veteran John W. Kuo as Chief Legal Officer

10/21/2021Press Release

Visby Medical Appoints Industry Veteran John W. Kuo as Chief Legal Officer

Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry.

Visby Medical Appoints Industry Veteran John W. Kuo as Chief Legal Officer

(SAN JOSE, CA), October 21, 2021Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry. In his new role, Kuo will lead legal strategy on all corporate initiatives and provide counsel to the executive leadership team and board of directors.

“I am pleased to welcome John to the Visby team,” said Visby Medical Founder and CEO Adam de la Zerda. “Our company has grown exponentially since launching our flagship COVID-19 and Women’s Sexual Health diagnostics, and John’s expertise will be an invaluable asset to the company as we move forward.”

Most recently, Kuo served as Executive Vice President of General Counsel and Chief Compliance Officer at Charles River Laboratories where he was responsible for overseeing legal, compliance, privacy, regulatory and security functions.  Previously, he was Senior Vice President, General Counsel and Corporate Secretary at Varian Medical Systems for over 15 years.  Prior to that, he held leadership positions at BroadVision and 3Com Corporation.  He also serves as the board for Mirion Technologies and several non-profit boards, including UC Berkeley Law’s Alumni Association, the Law Foundation of Silicon Valley, the Asian Pacific Fund and the Cornell University Council.

“Visby’s proprietary technology has the potential to be a real-world solution for diagnosing and treating infectious diseases,” said Kuo. “I look forward to playing an essential role in an organization focused on accelerating the field of diagnostics.”

Kuo has been recognized with multiple awards, including “Lifetime Achievement Award” by the Silicon Valley Business Journal, “Legal Department of the Year” by The Recorder and “Legend in Law” by the Burton Foundation. He began practicing law as an associate attorney with Norton Rose Fulbright in Houston after attending UC Berkeley School of Law and Cornell University.

About Visby Medical™

Visby Medical is a diagnostics company that is transforming the order of diagnosis and treatment for infectious diseases. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.

For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn at www.linkedin.com/company/visbymedical; Facebook, Instagram, and Twitter @VisbyMedical.

Contact: (240) 839-0945 | press@visby.com

Read more articles & insights

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

11/18/2023Viewpoint

A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

Read More
A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

03/14/2023Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women